Skip to main content
Log in

Multi-linear regression model, molecular binding interactions and ligand-based design of some prominent compounds against Mycobacterium tuberculosis

  • Original Article
  • Published:
Network Modeling Analysis in Health Informatics and Bioinformatics Aims and scope Submit manuscript

Abstract

Multidrug-resistant strains of Mycobacterium tuberculosis still remain a major challenge in creating first-hand drugs for treating tuberculosis. Development and syntheses of novel compounds with more potent anti-tubercular agents are usually by the trial and error approach which is time consuming and expensive. QSAR is a theoretical approach which has the potential to reduce the aforementioned problem in discovering new potent drugs against M. Tuberculosis. This approach was employed to develop the multivariate QSAR model to correlate the chemical structures of the 1,2,4-triazole analogues with their observed activities using a theoretical approach. To build the robust QSAR model, genetic function approximation was employed as a tool for selecting the best descriptors that could efficiently predict the activities of the inhibitory agents. The developed model was influenced with molecular descriptors, AATS7s, nHBint3, minHCsatu, TDB9e, RDF90i and RDF110s which have been validated through internal and external validation tests. Molecular docking studies were also carried for all the studied compounds to show the interactions and binding modes between the ligand and the receptor (DNA gyrase). The lead compound (compound 34) with higher anti-tubercular activity was observed with prominent binding affinity of 21.9 kcal/mol compared to the recommended drugs: isoniazid (− 14.6 kcal/mol) and ethambutol (− 5.8 kcal/mol). Therefore, compound 34 served as a template structure to designed compounds with more efficient activities. Among the compounds designed, compounds 34p, 34q and 34r were observed with better anti-tubercular activities with more prominent binding affinities which ranges from − 24.3 to − 28.6 kcal/mol. The outcome of this research is recommended for pharmaceutical and medicinal chemists to synthesize and carry out an in vivo and in vitro screening for the proposed designed compounds to substantiate the computational findings.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12
Fig. 13
Fig. 14
Fig. 15
Fig. 16

Similar content being viewed by others

References

  • Adeniji SE, Uba S, Uzairu A (2018a) QSAR modeling and molecular docking analysis of some active compounds against Mycobacterium tuberculosis receptor (Mtb CYP121). J Pathog 2018:1018694

    Article  Google Scholar 

  • Adeniji SE, Uba S, Uzairu A (2018b) A novel QSAR model for the evaluation and prediction of (E)-N′-benzylideneisonicotinohydrazide derivatives as the potent anti-Mycobacterium tuberculosis antibodies using genetic function approach. Phys Chem Res 6:479–492

    Google Scholar 

  • Adeniji SE, Uba S, Uzairu A (2018c) Theoretical modeling and molecular docking simulation for investigating and evaluating some active compounds as potent anti-tubercular agents against MTB CYP121 receptor. Future J Pharm Sci 4:284–295

    Article  Google Scholar 

  • Adeniji SE, Uba S, Uzairu A (2019) Geometrical and topological descriptors for activities modeling of some potent inhibitors against Mycobacterium Tuberculosis: a genetic functional approach. Egpt J chem 62:1635–1647

    Google Scholar 

  • Eric GM, Uzairu A, Mamza PAA (2016) Quantitative structure-activity relationship (QSAR) study of the anti-tuberculosis activity of some quinolones. J Sci Res Rep 10:1–15

    Google Scholar 

  • Hansch C, Kurup A, Garg R, Gao H (2001) Chem-bioinformatics and QSAR: a review of QSAR lacking positive hydrophobic terms. Chem Rev 101:619–672

    Article  Google Scholar 

  • Ogadimma AI, Adamu U (2016) Analysis of selected chalcone derivatives as Mycobacterium tuberculosis inhibitors. Open Access Libr J 3:1–13

    Google Scholar 

  • Roy K, Chakraborty P, Mitra I, Ojha PK, Kar S, Das RN (2013) Some case studies on application of “rm2” metrics for judging quality of quantitative structure–activity relationship predictions: emphasis on scaling of response data. J Comput Chem 34:1071–1082

    Article  Google Scholar 

  • Sarkar D, Deshpande SR, Maybhate SP, Likhite AP, Sarkar S, Khan A, Chaudhary PM, Chavan SR (2016) 1,2,4-triazole derivatives and their anti-microbial activity. Patient Google 2016

  • Singh P (2013) Quantitative structure-activity relationship study of substituted-[1,2,4] oxadiazoles as S1P1 agonists. J Curr Chem Pharm Sci 3:64–79

    Google Scholar 

  • Tropsha A, Gramatica P, Gombar VK (2003) The importance of being earnest: validation is the absolute essential for successful application and interpretation of QSPR models. Mol Inform 22:69–77

    Google Scholar 

  • Veerasamy R, Rajak H, Jain A, Sivadasan S, Varghese CP, Agrawal RK (2011) Validation of QSAR models-strategies and importance. Int J Drug Des Discov 3:511–519

    Google Scholar 

  • World Health Organization (2018) Tuberculosis fact sheet (no. 104) 2000. http://www.who.int/newsroom/factsheets/detail/tuberculosis

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shola Elijah Adeniji.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 394 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adeniji, S.E., Uba, S. & Uzairu, A. Multi-linear regression model, molecular binding interactions and ligand-based design of some prominent compounds against Mycobacterium tuberculosis. Netw Model Anal Health Inform Bioinforma 9, 8 (2020). https://doi.org/10.1007/s13721-019-0212-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s13721-019-0212-6

Keywords

Navigation